100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Full research proposal for course Designing research intervention. $9.13
Add to cart

Essay

Full research proposal for course Designing research intervention.

 15 views  0 purchase
  • Course
  • Institution

This course required to make a full grant research proposal for a self-chosen topic in the course 'Designing intervention research'. This proposal was rewarded with a 9/10.

Preview 3 out of 16  pages

  • February 7, 2023
  • 16
  • 2021/2022
  • Essay
  • Unknown
  • 9-10
avatar-seller
Faculty of Health, Medicine and Life Sciences




Registration form (basic details)



Submission date: April 29th, 2022




1b. Title of research proposal

NAD⁺: removing the ‘’long’’ out of long COVID?




1c. Scientific summary of research proposal (Pre-proposal)

SARS-CoV-2 infections commonly result in lasting side-effects, termed “long COVID”. Long COVID has
been reported to occur in up to 30% of infected individuals, who report fatigue and inflammation as
the most pronounced symptoms. The degree of fatigue and inflammation associated with long COVID
often withholds patients from returning to work or socialising normally, ultimately decreasing their
quality of life. The onset of fatigue is caused by the mechanism of SARS CoV-2 virus reproduction.
During a viral infection, the synthesis of Nicotinamide Adenine Dinucleotide (NAD⁺) consuming
enzymes are stimulated, which causes a drastic depletion of the NAD⁺ supply of the host cell. NAD⁺
depletion within the human body reduces Adenosine TriPhosphate (ATP)-production, resulting in
fatigue. Fatigue can be defined as a state of reduced mental and physical capability, from which
physical capability is frequently assessed by measuring VO₂peak. Moreover, an infection with the
SARS-CoV-2 virus leads to an over-expression of NAD⁺ consuming Poly [ADP-ribose] polymerases
(PARP)-genes in the infected patient, thereby causing an inflammatory response. NAD⁺ precursors
like Nicotinamide Riboside (NR) have been proposed to be a promising solution to counteract the
mechanisms related to fatigue and inflammation. NR supplementation raises blood NAD⁺ levels,
thereby increasing energy production. Therefore, this randomised double-blinded, placebo-
controlled trial aims to evaluate the effectiveness of 12-weeks of NR supplementation on long COVID
recovery measures (i.e. physical capability) in long COVID patients. Included subjects are aged 40-70
years, have had a confirmed COVID-19 infection at least 12 weeks prior, and are still experiencing
fatigue as quantified by Multidimensional Fatigue Evaluation (MAF). Subjects will be randomly
appointed to the intervention groups, after which they will ingest either a NR supplement
(1000mg/day) or a placebo (1000mg/day). At the beginning and at the end of the intervention, a




HMS4001 Designing Intervention research_application form 2021-2022 1

, Faculty of Health, Medicine and Life Sciences


VO₂peak test is performed and blood and muscle samples are taken for cytokine and gene expression
analysis.




1d. Keywords

Long COVID; Fatigue; Inflammation; NR supplementation; NAD+




HMS4001 Designing Intervention research_application form 2021-2022 2

, Faculty of Health, Medicine and Life Sciences




Research proposal



2a. Background of proposed research

Most people who get infected with the SARS-CoV-2 virus, return to their baseline state of health
within 3 to 4 weeks. However, when an individual has recovered from acute COVID-19, but is still
experiencing symptoms 12 week post infection, long COVID is diagnosed (1). Globally, the prevalence
of long COVID, 90 and 120 days post infection, is estimated to be 0.32 and 0.49 respectively (2). This
means that almost half of the people who get infected with the virus, still experience symptoms after
120 day. Considering approximately 460 million COVID recoveries worldwide (3), this is equivalent to
225 million people worldwide. The most common symptoms in affected individuals include extreme
fatigue, shortness of breath, and cognitive dysfunction (4). Not only patients experiencing severe
symptoms during acute infection are subject to long COVID, but also those who are only moderately
ill or even asymptomatic are susceptible to long COVID (5). Long COVID can be a debilitating
condition, affecting the daily lives of these patients; e.g. not being able to return to pre-infection
level of working, and accompanying psychological problems (6). Since, according to the World Health
Organisation (WHO), there currently is no specific treatment available for long COVID (7), finding
effective therapies for long COVID treatment is essential.

The most common symptom of long COVID is fatigue, reported in 53.1% of the cases (8). Fatigue can
be defined as a state of reduced mental and physical capability (9). Long COVID associated fatigue
has been proposed to impact skeletal muscle metabolic capacity (10). This can be seen by a decrease
in VO₂peak as it has been observed in other diseases with fatigue as a main symptom (11). The drop
in VO₂peak has been explained by a decrease in intramuscular substrates. Nicotinamide Adenine
Dinucleotide (NAD⁺) is a key substrate for energy production. A depletion in the NAD⁺ pool reduces
Adenosine TriPhosphate (ATP)-production. It is suggested that NAD⁺ depletion causes the
pathogenesis of SARS-CoV-2 infection and its long-term consequences. In acute COVID patients, a
depletion of NAD+ levels has been reported. Specifically, lower amounts of the NAD⁺ precursor are
present in the blood of COVID patients compared to healthy individuals (12). This can be explained by
a few mechanisms. In order to reproduce itself upon cell-entry, the virus uses NAD⁺ from its host cell.
Furthermore, this virus modulates the intensity of the immune response by over-expression of
proinflammatory NAD⁺-consuming Poly [ADP-ribose] polymerases (PARP)-genes in the infected
patient (13). When host cells are infected with SARS-CoV-2, the immune system is hyperactivated,
activating cytokine storms (14). These cytokine storms are triggered by an uncontrolled inflammatory


HMS4001 Designing Intervention research_application form 2021-2022 3

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller pascall076. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $9.13. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

53340 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$9.13
  • (0)
Add to cart
Added